Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedDec 22, 2024
DataAggregated Company Financials
Companies212
  • 7D-1.3%
  • 3M-13.4%
  • 1Y-3.9%
  • YTD-5.1%

Over the last 7 days, the Healthcare industry has dropped 1.3%, driven by a pullback from PharmaEssentia of 3.2%. On the other hand Caliway Biopharmaceuticals is actually up 6.5%. The industry has fallen 3.9% in the last year. As for the next few years, earnings are expected to grow by 56% per annum.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 22 Dec 2024NT$1.4tNT$245.0bNT$8.6b21.7x167.1x5.9x
Tue, 19 Nov 2024NT$1.5tNT$244.5bNT$8.0b22.6x183.4x6x
Thu, 17 Oct 2024NT$1.5tNT$236.4bNT$6.8b24.7x225x6.4x
Sat, 14 Sep 2024NT$1.6tNT$236.4bNT$6.8b24.9x232.1x6.6x
Mon, 12 Aug 2024NT$1.6tNT$230.0bNT$3.9b26.4x399.5x6.8x
Wed, 10 Jul 2024NT$1.7tNT$228.8bNT$3.6b28.7x461x7.2x
Fri, 07 Jun 2024NT$1.5tNT$228.6bNT$3.9b27.3x389.3x6.7x
Sun, 05 May 2024NT$1.4tNT$229.4bNT$4.5b25.5x321.9x6.3x
Tue, 02 Apr 2024NT$1.5tNT$228.8bNT$6.4b26.3x231.2x6.5x
Thu, 29 Feb 2024NT$1.5tNT$226.6bNT$6.7b25.8x219.3x6.5x
Sat, 27 Jan 2024NT$1.4tNT$225.0bNT$5.9b24.8x233x6.2x
Mon, 25 Dec 2023NT$1.4tNT$224.7bNT$5.9b25.5x239x6.2x
Wed, 22 Nov 2023NT$1.4tNT$224.7bNT$6.5b24.9x213.3x6.2x
Fri, 20 Oct 2023NT$1.3tNT$225.3bNT$8.3b24.4x160x5.9x
Sun, 17 Sep 2023NT$1.4tNT$225.2bNT$8.2b26.1x170.6x6.2x
Tue, 15 Aug 2023NT$1.3tNT$221.9bNT$7.0b24.6x187.8x6x
Thu, 13 Jul 2023NT$1.4tNT$226.5bNT$11.5b25.2x121.3x6.2x
Sat, 10 Jun 2023NT$1.4tNT$225.0bNT$11.1b24.9x130x6.4x
Mon, 08 May 2023NT$1.5tNT$220.1bNT$12.0b25.2x123.6x6.8x
Wed, 05 Apr 2023NT$1.4tNT$221.6bNT$13.1b22.1x108.8x6.4x
Fri, 03 Mar 2023NT$1.5tNT$215.2bNT$14.4b21.5x100.9x6.7x
Sun, 29 Jan 2023NT$1.3tNT$214.5bNT$13.8b20.1x94.3x6.1x
Tue, 27 Dec 2022NT$1.3tNT$214.5bNT$13.8b20.9x95.6x6.2x
Thu, 24 Nov 2022NT$1.3tNT$214.4bNT$14.1b17.5x92.5x6.1x
Sat, 22 Oct 2022NT$1.1tNT$207.4bNT$10.8b18.5x103.6x5.4x
Mon, 19 Sep 2022NT$1.4tNT$207.4bNT$10.8b21.4x131.3x6.8x
Wed, 17 Aug 2022NT$1.3tNT$207.7bNT$12.5b20.4x101.9x6.1x
Fri, 15 Jul 2022NT$1.2tNT$199.0bNT$9.8b21.8x121.3x6x
Sun, 12 Jun 2022NT$1.2tNT$207.9bNT$10.7b22.5x116.5x6x
Tue, 10 May 2022NT$1.2tNT$206.1bNT$12.3b22.1x98.7x5.9x
Thu, 07 Apr 2022NT$1.3tNT$204.7bNT$12.3b23.4x104.1x6.3x
Sat, 05 Mar 2022NT$1.2tNT$202.1bNT$14.3b22.8x86.4x6.1x
Mon, 31 Jan 2022NT$1.1tNT$202.1bNT$14.1b21.8x79.9x5.6x
Wed, 29 Dec 2021NT$1.2tNT$202.1bNT$14.1b21.8x83x5.8x
Price to Earnings Ratio

83x


Total Market Cap: NT$1.2tTotal Earnings: NT$14.1bTotal Revenue: NT$202.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Sector Price to Earnings3Y Average 172.9x202220232024
Current Industry PE
  • Investors are pessimistic on the Taiwanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 167x which is lower than its 3-year average PE of 173x.
  • The industry is trading close to its 3-year average PS ratio of 6.3x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 15% per year over the last three years.
  • Meanwhile revenues for these companies have grown 6.6% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

TW Market-2.11%
Healthcare-1.31%
Life Sciences1.91%
Pharma-0.011%
Healthcare Services-1.61%
Medical Equipment-2.00%
Biotech-2.58%
Healthtech-2.79%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 127x.
    • It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 82% over the next 5 years.
  • This is better than its past earnings growth rate of 8.8% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6919 Caliway BiopharmaceuticalsNT$603.006.5%
+NT$5.7b		207.7%PS1851.3x
6535 Lumosa TherapeuticsNT$196.505.1%
+NT$1.6b		193.3%PS856.9x
6617 Gongwin Biopharm HoldingsNT$111.509.3%
+NT$1.2b		-39.9%PS444.4x
6589 EirGenixNT$71.705.4%
+NT$1.1b		-28.7%PS18.7x
4178 StemCyte InternationalNT$35.1011.4%
+NT$685.9m		n/an/a
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6620

NT$54.50

Handa Pharmaceuticals

7D

5.0%

1Y

-72.2%

6446

NT$566.00

PharmaEssentia

7D

-3.2%

1Y

69.5%

Does PharmaEssentia (TWSE:6446) Have A Healthy Balance Sheet?

Dec 18
Does PharmaEssentia (TWSE:6446) Have A Healthy Balance Sheet?

6589

NT$71.70

EirGenix

7D

5.4%

1Y

-28.7%

6885

NT$31.20

BRIM Biotechnology

7D

-17.0%

1Y

5.9%

4743

NT$86.20

Oneness Biotech

7D

-3.1%

1Y

-53.5%

6785

NT$137.00

Alar Pharmaceuticals

7D

-6.2%

1Y

-34.4%

6919

NT$603.00

Caliway Biopharmaceuticals

7D

6.5%

1Y

207.7%

6535

NT$196.50

Lumosa Therapeutics

7D

5.1%

1Y

193.3%

6472

NT$737.00

Bora Pharmaceuticals

7D

-1.9%

1Y

14.8%

4123

NT$41.50

Center Laboratories

7D

-3.4%

1Y

-6.3%

6617

NT$111.50

Gongwin Biopharm Holdings

7D

9.3%

1Y

-39.9%

6550

NT$43.10

Polaris Group

7D

-9.2%

1Y

-44.5%

1799

NT$60.40

Easywell Biomedicals

7D

10.0%

1Y

45.2%

6808

NT$48.75

3D Global Biotech

7D

14.0%

1Y

147.5%